Skip to content
Case report Open access

Case Report: Unmasking catatonia in adolescents: a potential triggering role of corticosteroids in two clinical cases

Sep 2026 · Frontiers in Psychiatry · Vol 17 · 0 citations · 40 references
Medicine

TL;DR

Two adolescent girls who developed catatonia following corticosteroid therapy for suspected encephalitis, despite negative cerebrospinal fluid and blood markers are described, underscore that corticosteroid-induced catatonia can occur in adolescents and may complicate the differential diagnosis of neuropsychiatric syndromes.

Abstract

Background Catatonia is a transdiagnostic syndrome marked by motor, behavioral, and autonomic disturbances. Corticosteroids, commonly used to treat suspected neuroinflammatory conditions, may rarely precipitate or exacerbate psychiatric symptoms, including catatonia, in children and adolescents. Methods We describe two adolescent girls who developed catatonia following corticosteroid therapy for suspected encephalitis, despite negative cerebrospinal fluid and blood markers. Clinical courses, diagnostic workups, and therapeutic strategies (including benzodiazepines, antipsychotics, and immunomodulatory treatments) are detailed. A literature review of steroid-induced neuropsychiatric complications in pediatric populations was also performed. Results Both patients experienced temporal association between corticosteroid exposure and onset of catatonia. Standard first-line treatments were insufficient, and stabilization required antipsychotic therapy, including clozapine. Gradual improvement in baseline clinical status and recovery of lost functional abilities were observed during follow-up. These cases underscore that corticosteroid-induced catatonia, though rare compared to steroid-related psychosis, can occur in adolescents and may complicate the differential diagnosis of neuropsychiatric syndromes. Conclusions While corticosteroids remain essential for treating neuroinflammatory conditions, clinicians should be aware of the potential for severe psychiatric adverse effects, including catatonia, in pediatric patients. Careful differential diagnosis, interdisciplinary collaboration, and timely psychiatric intervention are critical to avoid iatrogenic worsening. Further research is needed to clarify underlying neurobiological mechanisms and identify markers of vulnerability, promoting safer and more personalized treatment approaches in children and adolescents.

Read PDF

Similar papers

Review Sep 2026

Pediatric catatonia across diagnostic contexts: Presentation, treatment course, and factors associated with ECT use.

Objective Catatonia in young people is increasingly recognized, but pediatric cohorts remain limited. We characterized clinical presentation and treatment course and examined factors associated with electroconvulsive therapy (ECT) use and exploratory inflammatory correlates of psychomotor dimensions. Methods We retrosp...

Alper Alnak, E. Koc, İpek Ege Gürel Fıçıcıoğlu et al. · 0 citations
Sep 2026

Electroconvulsive Therapy in Seronegative Paraneoplastic Encephalitis With Catatonia: Case Report.

Autoimmune encephalitis frequently presents with prominent psychiatric symptoms and may mimic primary psychiatric disorders, particularly in the early stages. We report the case of a 38-year-old man who presented with a 2-week history of behavioral disturbance, persecutory ideation, auditory hallucinations, and fluctua...

C. Sequeira, Maria João Brito, J. Andrade et al. · 0 citations
Sep 2026

A 6-Year-Old With Becker Muscular Dystrophy and Catatonia.

The case of a 6-year-old boy with acute behavioral changes in speech, affect, awareness, and new odd behaviors, admitted to a quaternary care pediatric hospital for further assessment and work-up of symptoms consistent with catatonia, and ultimately received electroconvulsive therapy highlights the importance of the id...

Stephanie A. Lichtor, Mars Robinson, J. Luccarelli et al. · 0 citations
Review Open access Sep 2026

416. Management of treatment-resistant catatonia: alternative therapeutic strategies

Abstract Background Catatonia is a severe neuropsychiatric syndrome characterized by behavioral, motor, and autonomic disturbances. It is associated with mood, psychotic disorders, encephalitis, thyroid disease, or delirium, but is often underdiagnosed, particularly in autism spectrum disorder. Its pathophysiology may...

I. Marques · 0 citations
Review Sep 2026

Clinical Recognition and Management of Catatonia: A Practical Guideline and Treatment Algorithm.

Importance: Catatonia is a neuropsychiatric syndrome characterized by abnormalities in motor behavior, speech, volition, and affect. Although historically associated with schizophrenia, contemporary diagnostic frameworks recognize catatonia as a transdiagnostic condition occurring across psychiatric, medical, and neuro...

Namratha Mohan, A. Sarangi · 0 citations
Open access Sep 2026

404. Hyperactive catatonia in autism and schizoaffective disorder: diagnostic pitfalls and pharmacological insights

A severe episode of hyperactive catatonia occurring in a patient with autism spectrum disorder (ASD) and schizophrenia conceptualized as schizoaffective disorder is described, emphasizing the clinical heterogeneity of catatonia and the risk of misattributing catatonic stereotypies to obsessive–compulsive phenomena.

A. Mitrea, D. Lambert, M. Kosel · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.